These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

376 related items for PubMed ID: 21566412

  • 1. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency.
    Miner MM, Khera M, Bhattacharya RK, Blick G, Kushner H.
    Postgrad Med; 2011 May; 123(3):17-27. PubMed ID: 21566412
    [Abstract] [Full Text] [Related]

  • 2. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
    Khera M, Bhattacharya RK, Blick G, Kushner H, Nguyen D, Miner MM.
    J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
    [Abstract] [Full Text] [Related]

  • 3. Testosterone deficiency.
    Traish AM, Miner MM, Morgentaler A, Zitzmann M.
    Am J Med; 2011 Jul; 124(7):578-87. PubMed ID: 21683825
    [Abstract] [Full Text] [Related]

  • 4. Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS).
    Blick G, Khera M, Bhattacharya RK, Nguyen D, Kushner H, Miner MM.
    Pain Med; 2012 May; 13(5):688-98. PubMed ID: 22536837
    [Abstract] [Full Text] [Related]

  • 5. 12-month observation of testosterone replacement effectiveness in a general population of men.
    Miner MM, Bhattacharya RK, Blick G, Kushner H, Khera M.
    Postgrad Med; 2013 Mar; 125(2):8-18. PubMed ID: 23816767
    [Abstract] [Full Text] [Related]

  • 6. Testosterone replacement therapy in men with hypogonadism and HIV/AIDS: results from the TRiUS registry.
    Blick G, Khera M, Bhattacharya RK, Kushner H, Miner MM.
    Postgrad Med; 2013 Mar; 125(2):19-29. PubMed ID: 23816768
    [Abstract] [Full Text] [Related]

  • 7. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
    Traish AM, Guay A, Feeley R, Saad F.
    J Androl; 2009 Mar; 30(1):10-22. PubMed ID: 18641413
    [Abstract] [Full Text] [Related]

  • 8. Risks of testosterone-replacement therapy and recommendations for monitoring.
    Rhoden EL, Morgentaler A.
    N Engl J Med; 2004 Jan 29; 350(5):482-92. PubMed ID: 14749457
    [No Abstract] [Full Text] [Related]

  • 9. The emerging link between hypogonadism and metabolic syndrome.
    Guay AT.
    J Androl; 2009 Jan 29; 30(4):370-6. PubMed ID: 18772486
    [Abstract] [Full Text] [Related]

  • 10. Testosterone deficiency and risk factors in the metabolic syndrome: implications for erectile dysfunction.
    Guay AT, Traish A.
    Urol Clin North Am; 2011 May 29; 38(2):175-83. PubMed ID: 21621084
    [Abstract] [Full Text] [Related]

  • 11. Androgen replacement therapy in late-onset hypogonadism: current concepts and controversies - a mini-review.
    Mäkinen JI, Huhtaniemi I.
    Gerontology; 2011 May 29; 57(3):193-202. PubMed ID: 20689266
    [Abstract] [Full Text] [Related]

  • 12. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM, Simhan J, Carson CC.
    BJU Int; 2009 May 29; 103(9):1179-83. PubMed ID: 19154450
    [Abstract] [Full Text] [Related]

  • 13. Hypogonadism and diabetes.
    Betancourt-Albrecht M, Cunningham GR.
    Int J Impot Res; 2003 Aug 29; 15 Suppl 4():S14-20. PubMed ID: 12934046
    [Abstract] [Full Text] [Related]

  • 14. Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism.
    La Vignera S, Calogero AE, D'Agata R, Di Mauro M, Tumino S, Condorelli R, Lanzafame F, Finocchiaro C, Giammusso B, Vicari E.
    Minerva Endocrinol; 2008 Sep 29; 33(3):159-67. PubMed ID: 18846023
    [Abstract] [Full Text] [Related]

  • 15. The role of accurate testosterone testing in the treatment and management of male hypogonadism.
    Dobs AS.
    Steroids; 2008 Dec 12; 73(13):1305-10. PubMed ID: 18639568
    [Abstract] [Full Text] [Related]

  • 16. The role of testosterone replacement therapy following radical prostatectomy.
    Khera M, Lipshultz LI.
    Urol Clin North Am; 2007 Nov 12; 34(4):549-53, vi. PubMed ID: 17983894
    [Abstract] [Full Text] [Related]

  • 17. Androgen deficiency in aging and metabolically challenged men.
    Shelton JB, Rajfer J.
    Urol Clin North Am; 2012 Feb 12; 39(1):63-75. PubMed ID: 22118346
    [Abstract] [Full Text] [Related]

  • 18. Testosterone replacement therapy in obese males.
    Drewa T, Olszewska-Słonina D, Chlosta P.
    Acta Pol Pharm; 2011 Feb 12; 68(5):623-7. PubMed ID: 21928705
    [Abstract] [Full Text] [Related]

  • 19. The dark side of testosterone deficiency: III. Cardiovascular disease.
    Traish AM, Saad F, Feeley RJ, Guay A.
    J Androl; 2009 Feb 12; 30(5):477-94. PubMed ID: 19342698
    [Abstract] [Full Text] [Related]

  • 20. LH and non-SHBG testosterone and estradiol levels during testosterone replacement of hypogonadal men: further evidence that steroid negative feedback increases as men grow older.
    Winters SJ, Wang C, Fortigel Study Group.
    J Androl; 2010 Feb 12; 31(3):281-7. PubMed ID: 19959827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.